MX2017001047A - Compuestos para usar en el tratamiento antihelmintico. - Google Patents

Compuestos para usar en el tratamiento antihelmintico.

Info

Publication number
MX2017001047A
MX2017001047A MX2017001047A MX2017001047A MX2017001047A MX 2017001047 A MX2017001047 A MX 2017001047A MX 2017001047 A MX2017001047 A MX 2017001047A MX 2017001047 A MX2017001047 A MX 2017001047A MX 2017001047 A MX2017001047 A MX 2017001047A
Authority
MX
Mexico
Prior art keywords
compounds
treatment
anthelminthic
anthelminthic treatment
disclosed
Prior art date
Application number
MX2017001047A
Other languages
English (en)
Inventor
Schwarz Hans-Georg
Welz Claudia
Köhler Adeline
Görgens Ulrich
Börngen Kirsten
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of MX2017001047A publication Critical patent/MX2017001047A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se divulgan compuestos de la fórmula (I) que poseen propiedades antihelmínticas (ver Fórmula) en la que los elementos estructurales tienen el significado indicado en la descripción. Además se divulgan tales compuestos para el control, el tratamiento y/o la prevención de las infecciones con helmintos en animales y seres humanos.
MX2017001047A 2014-07-25 2015-07-22 Compuestos para usar en el tratamiento antihelmintico. MX2017001047A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14178621 2014-07-25
EP15169965 2015-05-29
PCT/EP2015/066726 WO2016012485A1 (en) 2014-07-25 2015-07-22 Compounds for use in anthelminthic treatment

Publications (1)

Publication Number Publication Date
MX2017001047A true MX2017001047A (es) 2017-10-12

Family

ID=53610907

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001047A MX2017001047A (es) 2014-07-25 2015-07-22 Compuestos para usar en el tratamiento antihelmintico.

Country Status (14)

Country Link
US (1) US20170217931A1 (es)
EP (1) EP3172193A1 (es)
JP (1) JP2017521461A (es)
CN (1) CN107074803A (es)
AU (1) AU2015293966A1 (es)
BR (1) BR112017001384A2 (es)
CA (1) CA2955879A1 (es)
CL (1) CL2017000178A1 (es)
MX (1) MX2017001047A (es)
RU (1) RU2017105902A (es)
TW (1) TW201617330A (es)
UY (1) UY36196A (es)
WO (1) WO2016012485A1 (es)
ZA (1) ZA201701426B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3020793C (en) * 2016-04-15 2024-05-21 Bayer Animal Health Gmbh Pyrazolopyrimidine derivatives
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
US11485733B2 (en) * 2017-06-30 2022-11-01 Bayer Animal Health Gmbh Azaquinoline derivatives
CN111132977B (zh) * 2017-08-04 2024-07-23 礼蓝动物保健有限公司 用于治疗蠕虫感染的喹啉衍生物
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI435863B (zh) 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
KR20090016512A (ko) 2006-06-08 2009-02-13 신젠타 파티서페이션즈 아게 Ｎ-(ｌ-알킬-2-페닐에틸)-카복스아미드 유도체 및 살진균제로서의 이의 용도
ES2574821T3 (es) 2007-04-12 2016-06-22 Nihon Nohyaku Co., Ltd. Composición de agente nematicida y método de uso de la misma
WO2011020579A1 (de) 2009-08-20 2011-02-24 Bayer Cropscience Ag Verfahren zur herstellung von 1-phenyl-1,2,4-triazolen
CA2828060C (en) 2011-03-02 2018-11-06 The University Of Tokyo Endoparasite control agent
JP2015501326A (ja) * 2011-11-02 2015-01-15 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 殺線虫活性を有する化合物
US20140256728A1 (en) 2011-11-02 2014-09-11 Bayer Intellectual Property Gmbh Compounds with nematicidal activity
BR112014010707A2 (pt) 2011-11-04 2017-04-25 Syngenta Participations Ag compostos pesticidas
WO2013064518A1 (en) 2011-11-04 2013-05-10 Syngenta Participations Ag Pesticidal compounds
JP2014532683A (ja) 2011-11-04 2014-12-08 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
AU2012331256A1 (en) 2011-11-04 2014-05-22 Syngenta Participations Ag Pesticidal compounds
CN104203223A (zh) 2011-11-25 2014-12-10 拜耳知识产权有限责任公司 芳基甲酰胺和杂芳基甲酰胺作为杀体内寄生虫剂的用途
TWI654180B (zh) * 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
US9562034B2 (en) 2012-08-30 2017-02-07 The University Of Tokyo Endoparasite control agent
ES2661375T3 (es) 2012-08-30 2018-03-28 The University Of Tokyo Agente endoparasiticida y método para usarlo
AR097423A1 (es) * 2013-08-26 2016-03-16 Bayer Cropscience Ag Compuestos con actividad plaguicida

Also Published As

Publication number Publication date
ZA201701426B (en) 2018-12-19
JP2017521461A (ja) 2017-08-03
CL2017000178A1 (es) 2017-09-22
US20170217931A1 (en) 2017-08-03
BR112017001384A2 (pt) 2018-06-05
TW201617330A (zh) 2016-05-16
UY36196A (es) 2016-02-29
RU2017105902A (ru) 2018-08-27
CA2955879A1 (en) 2016-01-28
EP3172193A1 (en) 2017-05-31
AU2015293966A1 (en) 2017-02-02
CN107074803A (zh) 2017-08-18
WO2016012485A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MX2020005772A (es) Composiciones que comprenden cepas bacterianas.
MX2017005249A (es) Compuestos para usarse en el tratamiento antihelmintico.
HUE043341T2 (hu) Blautia hydrogenotrophica baktériumtörzset tartalmazó készítmények, hasmenés vagy székrekedés kezelésében vagy megelõzésében történõ alkalmazásra
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
MX2017006302A (es) Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
MX2018006239A (es) Composiciones que comprenden cepas bacterianas.
MX2018006398A (es) Composiciones que comprenden cepas bacterianas.
MX2018006399A (es) Composiciones que comprenden cepas bacterianas.
MX2017016564A (es) Composiciones que comprenden cepas bacterianas.
MX2017016560A (es) Composiciones que comprenden cepas bacterianas.
EP3188741A4 (en) Compositions and methods for the treating an inflammatory disease or disorder
WO2015003816A3 (en) Cystobactamides
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
EP3164125B8 (en) Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
PL3065732T3 (pl) Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii
EP3538189A4 (en) COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF CONDITIONS MEDIATED BY AN OPIOID RECEPTOR
PH12019502915A1 (en) Immunogenic compositions
MX2017001047A (es) Compuestos para usar en el tratamiento antihelmintico.
MX382092B (es) Compuestos heterocíclicos para el tratamiento de enfermedades.
KR101675359B9 (ko) 네오아가로올리고당을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 조성물
EP2982378A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE
IN2013MU03216A (es)
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions